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Stem cell differentiation involves critical changes in gene expression. Identification of these should provide endpoints
useful for optimizing stem cell propagation as well as potential clues about mechanisms governing stem cell
maintenance. Here we describe the results of a new meta-analysis methodology applied to multiple gene expression
datasets from three mouse embryonic stem cell (ESC) lines obtained at specific time points during the course of their
differentiation into various lineages. We developed methods to identify genes with expression changes that correlated
with the altered frequency of functionally defined, undifferentiated ESC in culture. In each dataset, we computed a
novel statistical confidence measure for every gene which captured the certainty that a particular gene exhibited an
expression pattern of interest within that dataset. This permitted a joint analysis of the datasets, despite the different
experimental designs. Using a ranking scheme that favored genes exhibiting patterns of interest, we focused on the
top 88 genes whose expression was consistently changed when ESC were induced to differentiate. Seven of these
(103728_at, 8430410A17Rik, Klf2, Nr0b1, Sox2, Tcl1, and Zfp42) showed a rapid decrease in expression concurrent with
a decrease in frequency of undifferentiated cells and remained predictive when evaluated in additional maintenance
and differentiating protocols. Through a novel meta-analysis, this study identifies a small set of genes whose
expression is useful for identifying changes in stem cell frequencies in cultures of mouse ESC. The methods and
findings have broader applicability to understanding the regulation of self-renewal of other stem cell types.
Citation: Glover CH, Marin M, Eaves CJ, Helgason CD, Piret JM, et al. (2006) Meta-analysis of differentiating mouse embryonic stem cell gene expression kinetics. PLoS Comput
Biol 2(11): e158. doi:10.1371/journal.pcbi.0020158
Introduction
Various types of stem cells are now recognized as
responsible both for the generation of tissues and organs
during embryonic development and also for the subsequent
maintenance and repair of these tissues and organs through-
out adult life. This has led to considerable interest in the
potential of these stem cell populations to be exploited as
cellular therapies for medical conditions where tissue damage
or malfunction is severe and irreversible. The clinical
realization of stem cell–based therapies will, however, rely
on the development of robust, scalable methods for the ex
vivo expansion and controlled manipulation of these cell
populations. Development of such protocols requires exten-
sive testing of multiple factors and culture conditions [1], but
this is currently inhibited by the lack of rapid endpoints of
stem cell frequency that can be used in high-throughput
assays.
The speciﬁc identiﬁcation of most stem cell types currently
relies on the use of functional assays to detect their
developmental potential, either in vitro or in vivo [2]. Such
assays are thus, by their very nature, retrospective, pro-
tracted, cumbersome, and labor-intensive. These features
make such assays impractical for large-scale studies and rapid
screening methodologies. Monitoring critical changes in gene
expression using either microarray or high-throughput
quantitative reverse transcription PCR (Q–RT–PCR) plat-
forms offers a potentially attractive solution but depends on
the identiﬁcation of a set of genes whose expression changes
predict decreased stem cell frequency with adequate pre-
cision and speciﬁcity.
Recently, several groups have described differences in the
gene expression proﬁles of several types of stem cells and
their differentiating progeny [3–8]. Most of these investiga-
tions have resulted in lists of genes that are too large for
comprehensive assessment of their functional signiﬁcance or
speciﬁcity. Moreover, many have focused on the detection of
altered patterns of gene expression that are more likely to be
indicative of emerging differentiated lineages than of altered
transcription of genes responsible for sustaining the stem cell
state. In many cases, the actual stem cell content of the
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cell subset. Mouse embryonic stem cells (ESC) are less
problematic in this regard because of their ease of prop-
agation in culture as a predominantly undifferentiated
population [9,10] and the availability of well-deﬁned proto-
cols for inducing their rapid differentiation into particular
lineages. A few genes that are important to the maintenance
of the pluripotent status of mouse ESC, such as Oct4 [11] and
Nanog [12], have been identiﬁed. However, recent studies of
the rate at which functional measures of stem cell frequency
of mouse ESC are lost indicated that these occur well before
changes in Oct4 expression are initiated [13]. The goal of this
study was to identify a robust set of early gene expression
changes that would be reliable indicators of decreased
pluripotent cell content in mouse ESC cultures, regardless
of the differentiation stimulus applied. In the following, the
ESC signature change is deﬁned as a set of gene expression
changes that are indicative of ESC loss from a population.
To identify candidates for inclusion in the ESC signature
change, we sought genes that exhibited a pattern of
expression consistent with functional assay output in three
independently generated datasets from ESC-derived cell
populations that had been treated for up to 96 h in several
ways to induce differentiation. This strategy required
innovation in statistical methodology since the ESC signature
change is more complicated than simple differential expres-
sion. Here, we present a statistically rigorous approach where
the probability that a gene exhibits a predetermined
expression pattern is estimated using a semiparametric
bootstrap. The deﬁnition of the ESC signature change was
speciﬁc to each experimental context, and, therefore, we
obtained from each dataset an objective summary of the
evidence that a gene is part of the ESC signature change.
Genes that exhibited the strongest evidence across all three
datasets were then tested in other maintenance or differ-
entiating conditions and shown to successfully predict func-
tional assay readout, indicating their potential to be used as
an assay in high-throughput screening experiments.
Results
Gene Expression Datasets
Gene expression data was obtained at several time points in
three independent experiments in which various differ-
entiation induction protocols were applied to three mouse
ESC lines. Summaries of each of the experiments are shown
in Table 1.
DMSO and retinoic acid-induced differentiation of R1
cells. Independent, duplicate cultures of R1 cells [14] were
cultured for 96 h with leukemia inhibitory factor (LIF) 6 2
lM retinoic acid (RA) or without LIF þ 1% DMSO. The
DMSO/RA dataset samples were hybridized to Affymetrix
MOE430 A and B Genechips (Table 1).
Induction of R1 cell differentiation by LIF removal. The
data for R1 LIF removal (R1–LR dataset) have been described
in detail previously [13]. Brieﬂy, R1 cells were cultured in the
absence of LIF for 0, 18, and 72 h. RNA for the 18-h sample
was generated from cells cultured in suspension, while RNA
for the 72-h sample was generated from cells cultured in
methylcellulose-containing medium. Samples were generated
independently in triplicate and hybridized to Affymetrix
MGU74v2 A, B, and C Genechips (Table 1).
Induction of R1, J1, and V6.5 differentiation by LIF
removal. The multiple cell line LIF removal (M–LR) dataset
is available from StemBase (http://www.scgp.ca:8080/
StemBase/) [15]. R1, J1 [16], and V6.5 [17] cells were
transferred onto 0.1% gelatin-coated dishes for 48 h with
LIF prior to inoculation in petri dishes in the absence of LIF
and RNA extracts obtained from 0 to 96 h later. RNA samples
were generated independently in triplicate and hybridized to
MOE430 A and B Affymetrix Genechips. (Table 1).
Functional Assay Analysis
To deﬁne the time course of changes in the biological
properties of ESC subjected to the differentiation protocols
used for gene expression analyses, R1 ESC were cultured on
0.1% gelatin-coated tissue-culture dishes with LIF 6 RA or
without LIF 6 DMSO, and aliquots were sequentially tested
in two-colony assays for undifferentiated cell activity The
colony-forming cell (CFC) assay performed in liquid cultures
containing LIF and the embryoid body (EB)-forming cell
assay performed in a semisolid medium without LIF (Figure
Table 1. Summary of All Microarray Experiments Used in This
Study
Experiment Details DMSO/RA R1–LR M–LR
Condition 1% DMSO/no LIF,
2 lM RA/10 ng/mL LIF,
10 ng/mL LIF
(positive control)
LIF removal LIF removal
Cell line R1 R1 R1, J1, V6.5
Timepoint (h) 96 0, 18, 72 0, 6, 12, 18,
24, 36, 48, 96
Number of replicates
per condition (total
number of chips)
2 (6) 3 (9) 3 (72)
Affymetrix chip MOE430 MG_U74v2 MOE430
Note that all replicates are biological.
doi:10.1371/journal.pcbi.0020158.t001
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Synopsis
Stem cells are able to develop into many specialized cell types and
thus have the potential to be used to repair or replace damaged
cells. One of the challenges that scientists face is learning how to
multiply these cells in vitro without loss of their stem cell properties.
The development of more rapid assays for stem cells in cultured
populations would significantly aid the optimization of culture
conditions for stem cells. The authors propose an assay for mouse
embryonic stem cells based on the expression change of seven
marker genes and show that it can detect both increases and
decreases in the frequency of stem cells. The assay was developed
by analyzing three independent microarray datasets that ask similar
biological questions but use different experimental designs. Gene
expression profiles were identified within each dataset that
exhibited patterns consistent with loss of stem cell properties,
and, using a novel statistical measure, these profiles were compared
between datasets in an unbiased fashion. A similar experimental
design could be used to develop other stem cell population assays,
and the analytical methods are adaptable to unrelated biological
questions where analysis of a diverse set of microarray experiments
is useful.
Gene Expression Indicators of ESC Pluripotency1A and 1B). The loss of these activities more closely parallels
the loss of stem cell activity measured by contribution to
chimeric mice than the loss of expression of SSEA-1 or Oct4
[13]. In the starting population, 20.9 6 0.2% of the R1 cells
were detectable as CFC and 11.2 6 0.4% gave rise to EB.
Exposure to RA had the fastest effect, causing a reduction of
both these values ;20-fold within 24 h, whereas simply
removing LIF (with or without DMSO addition) caused a
corresponding reduction of these values ;6-fold and 12-fold
in the same time frame. After 96 h, CFC and EB-forming cell
frequencies were less than 1% in all treated cultures. In
control cultures the frequencies of both CFCs and EB-
forming cells were sustained at half of the starting value, as
noted previously when R1 cells were transferred from
cultures containing feeders to gelatin-coated dishes [13].
To verify that each treatment induced cells to differentiate
towards different lineages, we used Q–RT–PCR to monitor
changes in transcript levels for ﬁve differentiation markers in
samples obtained after 96 h of treatment with the three
differentiation protocols (Figure 1C). All changes were
statistically signiﬁcant relative to the þLIF condition unless
otherwise stated. As expected, removal of LIF, with or without
DMSO treatment, induced the increased expression of genes
associated with ectoderm, neural, and mesoderm differ-
entiation (Fgf5 [18], Nestin [19], and brachyury [20], respec-
tively), but had little effect on the expression of genes
associated with endodermal differentiation (Foxa2 and Sox17
[21]). In contrast, treatment with RA strongly induced the
markers of neural and endodermal differentiation, but
decreased the expression of brachyury (mesodermal differ-
entiation) and had no signiﬁcant effect on Fgf5 expression
(ectodermal differentiation). Overall, all treatments gener-
ated mixed populations of cells.
Gene Expression Analysis
For the data from each experiment we applied a gene-
speciﬁc linear model to separate the observed expression into
a level for that gene under a reference condition (e.g.,þLIF or
time 0) plus effects due to treatment and random ﬂuctuation
due to biological variability and measurement error. For
example, to analyze the DMSO/RA dataset, the following
model was used:
expression ¼ expression in ‘‘ þ LIF’’
þchange due to treatment ðDMSO or RAÞ
þnoise
In this case, the three model parameters of primary interest
were: (1) the change attributable to the effect of DMSO, (2)
the change attributable to the effect of RA, and (3) the typical
magnitude of the noise. These changes can be visualized easily
by plotting parameter estimates on a ‘‘transcriptome plot’’
where each gene is represented by a single point (Figure 2A–
2C). For the data from the DMSO/RA experiments, most of
the genes in such a plot were found to lie close to the origin
(Figure 2A), indicative of their unaltered expression following
either treatment. However, it is interesting to note that for
those genes whose observed expression change was greater
than two in either treatment (463 genes), both treatments
appeared to have similar effects, as indicated by the fact that
98% of these were either increased (209 genes, top right
Figure 1. The Effect of LIF Removal with or without Addition of DMSO or RA on the Maintenance and Differentiation of ESC
(A) CFC frequency and (B) EB-forming ability of cells from the ESC cultures assessed at varying times after initiation of the treatment (þLIF controls¼&,–
LIF ¼ , –LIF þ DMSO ¼ m, þLIF þ RA ¼ .). * denotes the data for the þLIF sample are significantly different from all other treatments. (C) Gene
expression of differentiation markers was monitored by Q–RT–PCR after 96 h of treatment. Results shown are relative to the þLIF control cells.
doi:10.1371/journal.pcbi.0020158.g001
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Gene Expression Indicators of ESC Pluripotencyquadrant) or decreased (243 genes, bottom left quadrant) by
both treatments. A similar model was ﬁt to the R1–LR dataset
to obtain estimates of expression changes 18 and 72 h after
the removal of LIF, as well as a measure of the noise when this
differentiation induction protocol was used (Figure 2B).
For the M–LR dataset, use of an ANOVA-type model, such
as those described above, would have resulted in a large
number of model parameters. Since interpretability of the
parameters is so important in our context, we preferred a
smaller, smoother quadratic model based on time. This model
was able to capture the temporal trends of expression
changes, and principal component analysis strongly suggested
that a linear combination of constant, linear, and quadratic
terms explained almost all of the data variability (Figure 2C).
Identification of a Robust Set of Early Gene Expression
Changes That Indicate Decreased Frequency of
Undifferentiated ESC
We deﬁned the ESC signature change as a set of gene
expression changes that were associated with decreased
frequencies of ESC as indicated by functional assay readouts
during ESC culture. To identify genes that exhibit patterns
consistent with the ESC signature change, we imposed three
requirements on each dataset. When customized to a speciﬁc
experimental context, these requirements constitute an
expression-based deﬁnition of the ESC signature change, a
prerequisite for developing an appropriate statistical proce-
dure.
The three requirements used to select expression changes
for inclusion were: (1) large change in absolute magnitude, (2)
consistent change for all treatments and cell lines, and (3)
large change relative to gene-speciﬁc variability. The ﬁrst two
requirements can be visualized as retaining expression
changes falling in certain regions of the transcriptome plots
shown in Figure 2 (namely, those regions containing black
points). The third requirement cannot be visualized directly
in a transcriptome plot, but its effect is revealed by the fact
that some expression changes in the highlighted regions are
not retained, due to large gene-speciﬁc variance. Applica-
tions of these requirements are shown in Figure 2A–2C, with
full explanation detailed in Materials and Methods. Speciﬁc
values of the thresholds used for each dataset are shown in
Table 2.
Confidence Values
One way to detect ESC signature change genes is to identify
those whose observed expression patterns fall in regions of
interest in transcriptome plots (Figure 2). However, this
approach ignores the biological and technical noise con-
tained in the observed data. Furthermore, it fails to
distinguish between genes whose observed expression
changes barely fulﬁll our requirements from those that
substantially exceed the speciﬁed thresholds. For genes of
the latter type, we have more conﬁdence that their true, long-
run expression patterns are compatible with our deﬁnition of
the ESC signature change. We therefore decided to deﬁne
and exploit a probabilistic quantity that measured our
conﬁdence, given the observed data, that a gene exhibits an
expression pattern consistent with the ESC signature change
[22,23]. Within each experiment, we deﬁned a quantity pg for
each gene g: the probability that, in a hypothetical repeat of
the experiment, the observed expression change of this gene
would fulﬁll our requirements. Genes with true expression
changes that substantially exceed all relevant thresholds have
a pg greater than those that barely fulﬁll the requirements. If
two genes shared common expression changes but differed
with respect to their background variability, the pg of the gene
with less variability would be greater. Also, as biological
Figure 2. Transcriptome Plots of Estimated Expression Changes, Based on Fitting Models to Each Dataset
All plots have density shading to demonstrate the number of points (genes) in different regions. Lines illustrate examples of some of the requirements
that make up the definition of the ESC signature change and observed gene expression patterns that fulfilled all requirements are marked as ¤.
Experiment-specific implementations of requirements are explained below.
(A) DMSO/RA dataset. The requirement for large absolute changes is illustrated by the solid blue lines. Consistency across conditions implied that genes
must exhibit a change in the same direction in both treatments (bottom left or top right quadrant).
(B) R1–LR dataset. Note that the y-axis is the change seen at 72 h relative to that seen at 18 h. The requirement for large absolute changes is illustrated
by the solid blue lines. The criterion for consistency was applied by requiring that the change 18 h after LIF removal be in the same direction as that
after 72 h (i.e., in the lower left or upper right quadrants), regardless of its magnitude
(C) M–LR dataset. The requirement for large absolute changes is illustrated by the dashed blue lines. To meet the consistency criterion, we required that
a temporal gene expression trend either increase or decrease continuously over the duration of the experiment. This requirement was relaxed slightly
to retain trends with a direction change occurring either very early (red line) or very late (green line).
doi:10.1371/journal.pcbi.0020158.g002
PLoS Computational Biology | www.ploscompbiol.org November 2006 | Volume 2 | Issue 11 | e158 1466
Gene Expression Indicators of ESC Pluripotencyreplication increases, the pg of true ESC signature change
genes approach 1 and those of all other genes approach 0.
Just as p-values are used to rank genes with respect to
differential expression, we used pg to rank genes with respect
to their consistency with the ESC signature change. Note that
genes of primary interest have a pg value near 1, not near 0, as
is the case with p-values.
By deﬁnition, knowing pg requires knowledge of the true
change in expression following induction of differentiation,
whichisnotavailable.Therefore,weestimatedpgbycalculating
the proportion of bootstrap datasets in which gene g exhibited
data that fulﬁlled our requirements [23] and referred to this
quantity as the conﬁdence value (CV) [24]. All CVs are given in
Tables S1 and S2. The methods used to generate the bootstrap
data are described in the Materials and Methods and a more
detailed explanation is contained in Protocol S1.
Meta-Analysis via Pareto Optimization
After calculating CVs for all genes in the three experiments,
we conducted a meta-analysis to identify the gene expression
changes across all datasets most compatible with the ESC
signature change. Genes with expression changes most
correlated with decreased frequency of ESC pluripotency
would have CVs near 1 in all three experiments. If we were
working with only one dataset, we could rank the genes by CV
in decreasing order. However, with CVs arising from two or
more datasets, the task of ranking becomes considerably more
difﬁcult. In fact, it is only possible to partially order the genes,
and we accomplished this with Pareto Front Analysis (PFA)
[25]. Brieﬂy, in PFA, a comparison is made between all pairs of
genes and gene g is said to dominate gene k if, in all
experiments, the CVs of gene g are greater than or equal to
those of gene k, with strict inequality in at least one
experiment. The set of genes not dominated by any others is
called the ﬁrst Pareto front (PF) and contains the most
promising candidates for the ESC signature change. This set is
removed from the analysis and the same principle of
nondomination is then used to derive successive PFs (Figure
3). A more detailed explanation of PFA can be found in [25].
The ﬁrst ﬁve PFs identiﬁed changes in expression of 89
probesetsrepresenting88genes(10,7,17,27,and28probesets
onPFs1 to5,respectively).The genesonPFs1and2are shown
in Table 3 and the additional three are listed in Table S3.
Q–RT–PCR of Array Results
Experiments were undertaken to test, by an independent
strategy, the consistency of the candidates identiﬁed from the
analysis with the deﬁnition of the ESC signature change.
Accordingly, RNA extracts were prepared from R1 and J1
cells cultured for 0, 24, 72, and 96 h with LIF 6 RA or without
LIF 6 DMSO. Q–RT–PCR was used to measure the changes in
levels of 22 selected transcripts (relative to the cells cultured
in the presence of LIF). Nine of these were for genes in the
ﬁrst PF (103728_at, Esrrb, Nr0b1, Tcl1, Hck, Gbx2, Klf2, Fbxo1,5
and Spp1), four for genes in the second PF (Tcfcp2l1,
8430410A17Rik, Zfp42, Klf4), ﬁve for genes in the third PF
(Sox2, Jam2, Morc, Podxl, Sod2), two in the fourth PF (Nr1d2, Kit)
and two in the ﬁfth PF (Mtf2, Nmyc1). These genes were
purposefully chosen to have both high and moderate
conﬁdence in their ESC signature change membership (i.e.,
from the ﬁrst to the ﬁfth PFs). This tested the breadth of the
correlation between the Q–RT–PCR and array results across
the complete set of genes contained in the ﬁrst ﬁve PFs.
Q–RT–PCR results were compared with their correspond-
ing array data, except in the R1–LR dataset where the 24-hr
Q–RT–PCR results were compared with the 18-h array data.
All Q–RT–PCR data is shown in Table S4 and all comparisons
of the datasets for matched treatments are plotted in Figure 4
(see Figure 4A and 4B). Results from the Q–RT–PCR
measurements and the microarray analyses were strongly
correlated in both cell lines (R1 cell line: Figure 4A, r¼0.76; J1
cell line: Figure 4B, r¼0.82), although the individual changes
in gene expression measured by Q–RT–PCR were generally
larger than those apparent from the microarray data. There
was also a strong correlation between the data obtained for
the two different cell lines tested (r¼0.86, Figure 4C). Overall,
of the 22 genes tested, 18 demonstrated kinetics consistent
with array results when assessed using Q–RT–PCR (Table S4).
In particular, seven genes evaluated (i.e., from the ﬁrst PF:
103728_at, Klf2, Nr0b1, and Tcl1; from the second PF:
8430410A17Rik and Zfp42; and Sox2 from the third PF)
s h o w e dr a p i d( w i t h i n2 4h )a n ds u s t a i n e dc h a n g e si n
expression in both ESC lines in all differentiation induction
protocols (Figure 5). These seven genes were tested for their
ability to predict the time course of functional changes in
populations of ESC treated with another differentiation
protocol, i.e., exposure to 50 lg/mL ascorbic acid (AA) in the
absence of LIF, a treatment reported to promote the
generation of cardiac myocytes from undifferentiated ESC
[26]. Accordingly, R1 ESC were cultured for 5 d on 0.1%
gelatin-coated tissue-culture dishes in standard maintenance
conditions and with AA 6 LIF and changes in gene
expression compared with the loss of EB-forming potential.
As expected, EB potential decreased to 40% of its starting
value in the ﬁrst 24 h after transferring the cells to the control
(þLIF) conditions (without feeders) and then stayed constant
over the remaining 5 d of the experiment (Figure 6, see
Figure 6A). Cells cultured with AA in the absence of LIF
showed a rapid decrease in EB potential to almost undetect-
able levels by day 3. Interestingly, in the presence of AA and
LIF, there was an enhanced yield of EB-forming cells (with a
doubling of the proportion of EB-forming cells when
compared with the control þLIF conditions).
Figure 6B shows the time course of changes in transcript
levels for the seven genes that had previously been identiﬁed
as showing rapid changes in expression in all tested differ-
entiation conditions. It can be seen that all were reduced in
the cells exposed to AA in the absence of LIF, consistent with
the concordant rapid loss in EB potential. Moreover, when
AA was added in the presence of LIF, the level of expression
Table 2. Thresholds Used in the Definition of the ESC Signature
Change, in Terms of Gene Expression Changes
Parameter DMSO/RA R1–LR M–LR
Cabs 2.0, 2.3, 3.0 1.5, 1.7, 2.0 1.4, 1.8, 2.2
Cmin 0.4 (12 h)
Cmax 0.9 (68 h)
Crel 1.84 (DMSO),
2.72 (RA)
1.22 1.57
Number of Genes, CV . 0.5 265 269 240
doi:10.1371/journal.pcbi.0020158.t002
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consistent with their opposite biological response to the AA
treated cells in the absence of LIF. Zfp42 showed the most
rapid increase in expression in the AAþLIF-treated cells, and
the increase in expression of 103728_at and Sox2 were the
most delayed. Nevertheless, signiﬁcantly increased expression
of all seven genes relative to theþLIF controls was seen by 96
h. Together, these results indicate that changes in expression
of these seven genes can be used to infer concordant
functional changes in populations of ESC in culture.
Discussion
In this work, we have identiﬁed a small set of genes that
exhibit the ESC signature change, i.e., whose altered
expression is consistently and temporally correlated with an
altered frequency of functionally deﬁned, undifferentiated
cells in ESC cultures. This result is important because we had
previously found that signiﬁcant changes of more established
molecular markers of undifferentiated mouse ESC (Oct4 and
SSEA-1) may not occur until well after the biological
hallmarks of these cells have been lost [13]. By undertaking
an integrated analysis of gene expression changes induced by
exposure of ESC to multiple differentiation stimuli and the
use of objective statistical methods, we identiﬁed seven genes
whose altered expression correctly predicted concomitant
functional changes induced by other treatments. Importantly,
the expression changes of these genes reﬂected both
decreased and increased frequency of ESC.
Four of these seven genes have been shown previously to be
involved in the maintenance of mouse ESC or during early
development. These include Nr0b1 [27], Sox2 [28], Tcl1 [29],
and Zfp42 [30]. Among the remaining 81 genes on the ﬁrst ﬁve
PFs, an additional 11 have been reported to be involved in
some aspect of development (see Table S5). Most notably Hck
[31], Fbx015 [32], Dppa3/Stella [33], and Klf4 [34] have all been
speciﬁcally implicated in maintenance or differentiation of
ESC, while expression of Eed [35] is required for embryonic
viability before implantation. Interestingly, Oct4 [11] and
Nanog [12] were not included in the ﬁrst ﬁve PFs. While Oct4
was differentially expressed in both the DMSO/RA and M–LR
datasets, it was not changed in the R1–LR dataset as shown
previously [13]. Nanog was differentially expressed in both the
R1–LR and DMSO/RA datasets but did not show any change
in the M–LR dataset.
Several previous microarray studies have been performed
to uncover signalling pathways and regulatory factors
required for the maintenance of human and mouse ESC [3–
8,36,37]. These have each uncovered large numbers of genes
whose expression was increased or absent in undifferentiated
cells and, in some cases, little overlap has been found between
the genes thus affected [38,39]. As a further step towards
assessing the validity of our identiﬁed genes, we compared
our data with two previously published datasets that sought to
identify genes uniquely expressed in mouse ESC [4,5]. Of the
88 genes highlighted here, 75 were also changed in the other
datasets (Table S6). This high degree of correspondence
supported the validity of our very different approach to a
similar biological question. Interestingly, a comparison of our
results to genes whose expression has been reported to
accompany the differentiation of human ESC [3,6,36,37],
Figure 3. Two-way Pareto Front Analysis applied to CVs from the R1–LR Dataset and the M–LR Dataset
(Left) Shows the CVs for all comparable genes with the first five Pareto fronts highlighted (red, first PF; blue, second PF; green, third PF; gold, fourth PF;
black, fifth PF).
(Right) Shows a magnification of the dashed box in the left panel. Here the red gene is said to dominate all other genes because, although it has an M–
LR CV equal to that of several other genes, it has the highest R1–LR CV. Thus it lies on the first PF. In the same way, the blue gene dominates all genes
except the red gene and thus lies on the second PF. It is not possible to choose between the two green genes because they each have larger CVs in one
of the two experiments. They, therefore, lie on the same (third) PF. The highlighted yellow gene does have a larger CV in the R1–LR dataset than the
green gene on the left but it falls on a lower PF because it is completely dominated by the green gene on the right.
doi:10.1371/journal.pcbi.0020158.g003
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Gene Expression Indicators of ESC Pluripotencyrevealed far fewer similarities, as reported by others [40]. We
f o u n dt h a to n l y2 6o ft h e8 8g e n e se x h i b i t e ds i m i l a r
expression changes in at least one of the four human ESC
studies. Moreover, in some cases, the gene expression level
changed in the opposite direction. For example, in this work,
Podxl was found to be strongly increased as mouse ESC
differentiate, whereas the human homolog was found to be
decreased in three studies of human ESC differentiation
[3,6,37]. Overall, only six of the 88 genes were not identiﬁed as
being altered in any other published datasets of differ-
entiating ESC.
The goal of this work was to identify a small number of
genes suitable for the development of an expression-based
assay to estimate the frequency of ESC in culture. To achieve
this, we have taken care to seek gene expression changes that
fulﬁll several criteria beyond simple differential expression,
including large, rapid, and consistent changes in more than
one cell line following the induction of differentiation using
multiple methods. In terms of statistical analysis, we required
(1) a quantitative index that reﬂected each gene’s compliance
with the predeﬁned ESC signature change (for use within
each dataset); and (2) a meta-analytic procedure for ranking
genes based on their compliance with the ESC signature
change deﬁnition in multiple datasets.
Figure 4. Comparison of Differently Measured Changes in Gene Expression within and between Two ESC Lines Grown for 0, 24, 72, and 96 h inþLIF 6
RA or –LIF 6 DMSO
(A) Comparison of Q–RT–PCR and microarray results for the R1 line (r ¼ 0.76).
(B) Comparison of Q–RT–PCR and microarray results for the J1 line (r ¼ 0.82).
(C) Comparison of results between the R1 and J1 lines (r ¼ 0.87).
doi:10.1371/journal.pcbi.0020158.g004
Figure 5. Q–RT–PCR Profiles of Transcript Levels for Seven Genes That Showed Rapid Decrease in ESC Populations When Subjected to a Variety of
Differentiating Conditions
All levels of expression are relative to the þLIF control. þLIF control ¼ &, –LIF ¼ , –LIF þ DMSO ¼ m, þLIF þ RA ¼ ..
doi:10.1371/journal.pcbi.0020158.g005
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Gene Expression Indicators of ESC PluripotencyAs our quantitative index, we chose the probability that a
gene would exhibit the ESC signature change in a hypo-
thetical repeat of the experiment, instead of the more
conventional p-value, the probability that a gene would
exhibit data as, or more ‘‘extreme’’ than, the observed change
if its true expression were unchanged in the study. This
choice was necessitated because in our application the ESC
signature change is deﬁned by more than a requirement for
differential expression. In the majority of microarray
applications, the genes of interest are characterized by
differential expression, where the complementarity of the
null hypothesis (no differential expression) and the bio-
logically interesting state (differential expression) permits the
p-value to serve as an index of biological interest. Here we
employed an index that originates with an explicit deﬁnition
of the biologically interesting target proﬁle. This is an
application of methods previously described for identifying
genes with biologically speciﬁc expression patterns [22,23].
The task of identifying ESC signature change genes can be
viewed also as an instance of the so-called ‘‘problem of
regions’’ [24], in which the term ‘‘conﬁdence value’’ is ﬁrst
established. In certain settings, CVs can be shown to be
approximations of Bayesian a posteriori probabilities.
Although not formally established here, the CV can be
interpreted heuristically as the posterior probability that a
gene truly exhibits the ESC signature change.
As our method of meta-analysis, we used PFA [25] to
(partially) rank genes based on three independent measures
of ESC signature change compliance, as opposed to the more
prevalent practice of integrating experiment-speciﬁc fold-
changes [41,42], p-values[43,44], test statistics [45,46], or effect
size estimates [47,48]. In these works, the common goal is a
uniﬁed list of differentially expressed genes that is accom-
panied by an estimated error rate, usually the false discovery
rate [49,50]. The methodological choices and innovations of
this work are motivated by departures from this common
goal, and our techniques may prove useful in other studies
where biological interest is not synonymous with differential
expression. PFA was ﬁrst applied to gene expression data by
Fleury et al. [25]. In that work, PFA was used to optimize
multiple indices within one study as opposed to our use,
which is the optimization of a comparable index, the CV,
across distinct but related studies. Yang et al. present another
compelling technique for the synthesis of competing meas-
ures of differential expression within a single experiment
[51], and it may be possible to extend their methodology for
use in meta-analysis.
Meta-analysis of microarray data is an increasingly com-
mon technique to capitalize on the combined power of
biologically related but distinct datasets [41–48]. In addition
to the usual advantage of increasing the effective sample size,
the primary beneﬁt of meta-analysis in our application is to
insulate our biological ﬁndings from confounding exper-
imental and biological effects [44,46]. For example, in the R1–
LR dataset, changes induced by differentiation could have
been confounded with changes caused by the removal of
feeders from the culture. However, this effect was not present
in the other datasets; therefore, any common gene expression
changes cannot be attributed to the removal of feeders. An
example of profound differences in gene expression caused
by small changes in culture conditions was reported by
Skottman et al., who demonstrated effects on 1,417 genes in
human ESC cultured in serum containing versus serum-free
conditions, despite comparable levels of expression of other
markers of their undifferentiated state [52].
In summary, meta-analysis of multiple gene expression
datasets from populations of mouse ESC induced to differ-
entiate has revealed multiple genes whose altered expression
provides a robust and timely indication of changes in
pluripotency. These ﬁndings suggest the importance of the
products of these genes in the molecular regulation of the
undifferentiated state of ESC and provide a useful basis for
developing high-throughput approaches for the bio-monitor-
ing of ESC cultures.
Figure 6. Comparison of Biological and Molecular Changes in ESC Stimulated to Differentiate by Exposure to AA
(A) Changes in EB frequency.
(B) Changes in the levels of transcripts for seven ESC signature change genes measured by Q–RT–PCR. þLIF (&), þLIF þ AA ( ), and –LIF þ AA (m).
doi:10.1371/journal.pcbi.0020158.g006
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Gene Expression Indicators of ESC PluripotencyMaterials and Methods
ESC maintenance cultures. J1 (passage 14) and R1 (passage 17) ESC
lines were maintained on irradiated feeders at 37 8Ci n5 %C O 2 in air
with daily exchange of ESC maintenance medium consisting of high
glucose Dulbecco’s Modiﬁed Eagles Media supplemented with 15%
pre-screened fetal bovine serum (FBS), 0.1 mM nonessential amino
acids, 2 mM glutamine, 100 U/mL penicillin, 100 lg/mL streptomycin,
10 ng/mL LIF (all reagents from StemCell Technologies, http://www.
stemcell.com) and 100 lM monothioglycerol (MTG, http://www.
sigmaaldrich.com). Cells were passaged every second day. Primary
mouse embryo feeders (StemCell Technologies) were maintained at
37 8Ci n5 %C O 2 in air in DMEM supplemented with 10% FBS, 1 mM
glutamine, 100 U/mL penicillin, 100 lg/mL streptomycin, and 100 lM
MTG. Feeders were irradiated by exposure to 80 Gy 300 kvP X-rays.
ESC experimental cultures. Cells were thawed and maintained on
irradiated feeders for two passages prior to initiation of differ-
entiation cultures. To remove contaminating feeders, cells harvested
from maintenance cultures were plated onto tissue culture dishes
(Sarstedt, http://www.sarstedt.com/php/main.php) in maintenance
medium for 1 h at 37 8C. All suspended and loosely adherent cells
were harvested by gently pipetting medium onto the surface of the
tissue-culture dish. Following this, feeder contamination was esti-
mated at ,1% based on cell size during counting.
Experimental cultures were performed on tissue culture dishes
(Sarstedt), coated with 0.1% porcine gelatin (Sigma) with cells plated
at a density of 80–1,500 cells per cm
2 depending on the day of harvest.
Differentiation media were based on maintenance medium with the
following differences; (a) LIF removal—maintenance medium minus
LIF, (b) DMSO—maintenance medium minus LIF plus 1% DMSO
(Sigma), (c) RA—maintenance medium plus 2 lM RA (Sigma), (d) AA
þ LIF—maintenance medium plus 50 lg/mL AA (Sigma), and (e) AA-
LIF—maintenance medium without LIF plus 50 lg/mL AA. Concen-
trated RA was prepared at a concentration of 10 mM by dissolving 30
mg powder in 10 mL 100% ethanol and stored at 4 8C in the dark.
Media was prepared by adding 10 lL of RA stock solution to 50 mL
maintenance media. Cells were harvested daily for functional assay
analysis (CFC and EB assays, see below) or for RNA extraction.
Colony forming cell assay. Test cells were plated at a density of
1,000–2,500 cells on gelatinized 60-mm tissue-culture dishes (with
grid) in maintenance medium at 37 8Ci n5 %C O 2 in air. Five days
later, colonies were stained for alkaline phosphatase (Kit 86-R; Sigma)
and counted. Colonies were classiﬁed as differentiated (colourless),
undifferentiated (pink), or mixed. Assay output was calculated as the
percentage of undifferentiated colonies based on the assay seeding
density.
Embryoid body assay. Test cells were plated at a density of 1,000–
5,000 cells per 35-mm low-adherence petri dish in Iscove’s Modiﬁed
Dulbecco’s Media supplemented with 15% prescreened FBS, 0.9%
methylcellulose, 2 mM glutamine, and 150 lM MTG (all reagents from
StemCell Technologies). EB were counted 5 d later and the frequency
of EBs was calculated as the number of EBs generated per 100 ESC
plated.
RNA extraction and array hybridization. Cytoplasmic RNA was
extracted using the RNeasy mini kit (Qiagen, http://www1.qiagen.
com). Standard Affymetrix protocols (Affymetrix, http://www.
affymetrix.com/index.affx) were used to generate RNA probes from
5 lg of extracted RNA. Samples were hybridized to MOE430 A & B
chips on a Genechip system (Affymetrix) at the Ottawa Genomics
Innovation Centre (http://www.ottawagenomecenter.ca/) according to
the manufacturer’s instructions.
Gene expression analysis. In this analysis, as is common practice
hybridization data for each probeset was considered independently,
although we recognize that transcripts for many genes would be
captured by multiple probesets. Furthermore, although the corre-
spondence between probeset and gene is not, as a rule, one-to-one,
we refer to the expression from each probeset as if it reﬂected the
expression of one gene, unless otherwise stated.
All preprocessing, including background correction, normaliza-
tion, probeset summarization, and log2 transformation, was carried
out with the RMA algorithm [53] in the affy package [54] from
Bioconductor [55] and processed data returned by RMA are referred
to as expressions. The R code [56] for all the data analysis shown
below is available from http://www.stat.ubc.ca/;jenny/webSupp/
gloverSCmeta/index.html.
In the equations below we followed these conventions:
Observed intensities were denoted by Yi,cond, where i indexed the
biological replicate, i.e., i 2f 1 ,...,N g, and cond denoted the
corresponding condition, i.e., treatment or time.
All models are gene-speciﬁc, although, for the sake of simplicity, an
explicit index for gene was avoided.
Within the observations for one gene, the random errors e were
assumed to be independent and identically distributed and to have
expectation zero and a ﬁnite, gene-speciﬁc variance r2
exp, where exp is
DMSO/RA, R1–LR, or M–LR.
To summarize gene expression changes, we ﬁt linear models to the
RMA processed data. For the DMSO/RA data we used the following
model:
Yi;cond ¼ lþLIF þ bcond þ ei;cond
where lþLIF was the expected intensity in theþLIF control condition,
bþLIF ¼ 0 by deﬁnition, and bDMSO (bRA) was the effect of DMSO (RA)
treatment, relative to þLIF.
For the R1–LR data we used the following model:
Yit ¼ l0h þ b18h   It 18h þ b72h   It 72h þ eit
where l0h was the expected intensity at time 0, b18h (b72h) was the
effect of 18 h versus 0 h (72 h versus 18 h), and Istatement was 1 if the
statement was true and Istatement was 0 otherwise.
For the M–LR data we used the following model:
Yit ¼ l0 þ blint þ bquadt2 þ eit ð1Þ
where l0 was the expected intensity at time 0, t was log2 transformed
and centered time where 0 h was changed to 3 h to avoid undeﬁned
values, and blin and bquad gave the linear and quadratic effects of time,
respectively.
Deﬁning the ESC signature change in terms of gene expression.
For the DMSO/RA data, a gene had to fulﬁll the following require-
ments to be included in the ESC signature change:
Absolute change: bcond . Cabs, or bcond , –Cabs for cond¼DMSO and
cond ¼ RA
Changerelative to variability:
jbcondj
r .Crel for cond¼DMSO and cond¼RA
Consistency: bDMSO . 0 and bRA . 0, or bDMSO , 0 and bRA , 0
For the R1–LR data, expression requirements were as follows:
Absolute change: b18h þ b72h . Cabs, or b18h þ b72h , Cabs
Change relative to variability:
jb18hþb72hj
r .Crel
Consistency: b18h   0 and b72h   0, or b18h   0 and b72h   0
For the M–LR data, the deﬁnition of an interesting expression
pattern was more complicated. We required a large absolute
difference in the expected expression intensity between the start
time, tmin, of the study and the end, tmax. Speciﬁcally, we required that
jEðYtmaxÞ EðYtminÞj.Cabs
Given Equation 1, it can be shown that this is equivalent to the
following requirement:
bquad.
Cabs
TD1
 
TD1
TD2
blin or bquad ,
 Cabs
TD1
 
TD1
TD2
blin
where TDk ¼ tk
max   tk
min. The relative expression change requirement
that
jEðYtmaxÞ EðYtminÞj
r
.Crel
is equivalent to the following condition:
bquad.
Crel
TD2
r  
TD1
TD2
blin or bquad ,
 Crel
TD2
r  
TD1
TD2
blin
Consistency was built into the ESC signature change deﬁnition by
noting the location in the time course of the vertex of the quadratic
ﬁt (Equation 1). The requirement for strictly increasing or decreasing
expression patterns was relaxed by allowing genes whose vertex fell
before Cmin or after Cmax to be retained, where Cmin and Cmax were
speciﬁed relative to the standardized, transformed study time. This
requirement is captured in the following condition:
 
blin
2bquad   tmin

TD2
,Cmin or
 
blin
2bquad   tmin

TD2
.Cmax
In all experiments, the speciﬁc values of the user-speciﬁed
thresholds are given in Table 2. Note that the ﬁnal results of this
analysis are highly robust to modest differences in these thresholds.
Conﬁdence values. One thousand simulated datasets were gen-
erated for each of the original datasets by adding the original ﬁtted
averages and a randomly sampled residual (with replacement) from
the residuals associated with that gene within the dataset. Note that
for the M–LR dataset, the bootstrap data was derived from time and
cell line speciﬁc averages and residuals, not from quadratic ﬁts. To
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Gene Expression Indicators of ESC Pluripotencymaintain the covariance between genes, the same random selection of
residuals were used for all genes in a simulated dataset. The simulated
data was then assessed relative to the ESC signature change
deﬁnitions given above. The proportion of times that a gene fulﬁlled
the deﬁnition, i.e., the CV, was calculated. As a practical measure,
within each experiment, we used several values for Cabs and averaged
the resulting CVs to obtain the CVs used for PFA. This was an
expedient method for reducing the frequency of CVs equal to 0 or 1,
which are highly undesirable for PFA. The use of multiple thresholds
makes the ﬁnal results of our analysis robust to modest changes. The
most stringent values of Cabs were chosen such that the number of
genes retained in each dataset was approximately equal, and a range
of less stringent thresholds was applied to create further distinction
among the CVs.
Comparison of MOE430 and MG_U74v2 chips. To compare gene
samples hybridized to the MOE430 and MG_U74 chips, six different
comparisons were used. Two comparisons were generated from the
Affymetrix-deﬁned ‘‘good’’ or ‘‘best’’ comparisons (for more infor-
mation see http://www.affymetrix.com). Resourcerer [57] was used to
generate lists of comparable probesets based on EGO, Unigene,
Locuslink, and Refseq comparisons. A list of two-way comparable
probesets was generated by ordering evidence for comparison as
follows: Affymetrix Best . Affymetrix Good . EGO . Unigene ¼
Locuslink¼Refseq. In this way 21,271 one-to-one mappings between
the two chips were made (Table S7).
Gene ontology. Functional information about differentially ex-
pressed genes was obtained by loading Affymetrix identiﬁers into the
Database for Annotation, Visualization, and Integrated Discovery 2.0
(DAVID2) [58]. Gene ontologies were determined and compiled at
several different levels of the ontology.
Quantitative reverse transcription-PCR. Q–RT–PCR was per-
formed as previously described [13]. Relative expression changes
were determined with the 2
 DDCT method [59] and the Gapdh
transcript was used to normalize results between samples. Primers
were manufactured by Invitrogen (http://www.invitrogen.com/) and
sequences are shown in Table S8.
Supporting Information
Protocol S1. Example of Conﬁdence Value Calculation
Found at doi:10.1371/journal.pcbi.0020158.sd001 (89 KB PDF).
Table S1. Conﬁdence Values for All Genes in the R1–LR Dataset
Found at doi:10.1371/journal.pcbi.0020158.st001 (686 KB PDF).
Table S2. Conﬁdence Values for All Genes in the DMSO/RA Dataset
and M–LR Dataset
Found at doi:10.1371/journal.pcbi.0020158.st002 (859 KB PDF).
Table S3. The First Five Pareto Fronts
Found at doi:10.1371/journal.pcbi.0020158.st003 (18 Kb PDF).
Table S4. Raw Data from Q–RT–PCR
Found at doi:10.1371/journal.pcbi.0020158.st004 (8 KB PDF).
Table S5. Biological Process and Molecular Function Classiﬁcation of
Genes in Pareto Fronts
Found at doi:10.1371/journal.pcbi.0020158.st005 (8 KB PDF).
Table S6. Comparison of Table S3 with Other Publications
Found at doi:10.1371/journal.pcbi.0020158.st006 (61 KB PDF).
Table S7. Probeset Translations between the MG_U74v2 and MOE430
Genechips
Found at doi:10.1371/journal.pcbi.0020158.st007 (365 KB PDF).
Table S8. Primers Used for Q–RT–PCR
Found at doi:10.1371/journal.pcbi.0020158.st008 (18 KB PDF).
Accession Numbers
Accessions numbers from the Ensembl database (http://www.ensembl.
org/index.html) for the genes mentioned in this paper are: 103728_at
(ENSMUST00000027649), 8430410A17Rik (ENSMUST00000032141),
Klf2 (ENSMUST00000067912), Nr0b1 (ENSMUST00000026036), Sox2
(ENSMUST00000099151), Tcl1 (ENSMUSG00000041359), Zfp42 (EN-
SMUST00000082120), Oct4 (ENSMUST00000025271), Nanog (EN-
SMUST00000012540), Fgf5 (ENSMUST00000031280), Nestin
(ENSMUST00000090973), Brachyury (ENSMUST00000074667), Foxa2
(ENSMUST00000047315), Sox17 (ENSMUST00000027035), Esrrb (EN-
SMUST00000021680), Hck (ENSMUST00000003370), Gbx2 (EN-
SMUST00000036954), Fbxo15 (ENSMUST00000037718), Spp1
(ENSMUST00000031243), Tcfcp2l1 (ENSMUST00000027629), Jam2
(ENSMUST00000057513), Morc (ENSMUST00000023330), Podxl (EN-
SMUST00000026698), Sod2 (ENSMUST00000007012), Nr1d2 (EN-
SMUST00000090543), Kit (ENSMUST00000005815), Mtf2
(ENSMUST00000081567), Nmyc1 (ENSMUST00000043396), Dppa3/
Stella (ENSMUST00000049644), Klf4 (ENSMUST00000003116), Eed
(ENSMUST00000032850), Gdf3 (ENSMUST00000032211), Krt1–18
(ENSMUST00000023803), Krt1–19 (ENSMUST00000007317), Cldn7
(ENSMUST00000018713), Manba (ENSMUST00000029814), Cobl (EN-
SMUSG00000020173), and Jmjd1a (ENSMUSG00000053470).
Accessions numbers from the ArrayExpress database (http://www.
ebi.ac.uk/arrayexpress) for the microarrays mentioned in this paper
are: for the DMSO/RA dataset (E-MEXP-412), and for the R1-LR
dataset (E-MEXP-414).
Accession numbers from the Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo) for RNA samples mentioned in this paper
are: R1 data (GSE2972), V6.5 data (GSE3231), and J1 data (GSE3749).
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